Glucose Infusion Rate (GIR)
ورودیهای بالینی بیمار
حداقل ۰.۱ — حداکثر ۱۰۰۰ • واحد: mL/hr
حداقل ۱ — حداکثر ۵۰ • واحد: %
حداقل ۰.۵ — حداکثر ۲۰۰ • واحد: kg
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Below Normal Range0–3.9
- Normal/Physiologic Range4–8
- Moderate/Therapeutic Range8.1–12
- High Therapeutic Range12.1–18
The Glucose Infusion Rate (GIR) calculator is designed for bedside calculating the rate at which glucose is administered intravenously, particularly important in neonatal and pediatric care to maintain appropriate blood glucose levels in clinical practice. The resulting score directly guides clinician decision-making regarding titrating insulin.
Clinical Guidelines & Evidence
Calculates the rate at which glucose is administered intravenously, particularly important in neonatal and pediatric care to maintain appropriate blood glucose levels. Used to monitor and adjust dextrose infusions to prevent hypoglycemia while avoiding excessive glucose administration.
Clinical Indication
The Glucose Infusion Rate (GIR) is indicated for bedside clinical practice to support Calculates the rate at which glucose is administered intravenously, particularly important in neonatal and pediatric care to maintain appropriate blood glucose levels. Used to monitor and adjust dextrose infusions to prevent hypoglycemia while avoiding excessive glucose administration.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.
Limitations & Contraindications
Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.
Clinical Pearls & Action Plan
Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management. Guideline pearl: Gradual GIR reduction recommended when transitioning to enteral feeding.
GIR (mg/kg/min) = [Infusion rate (mL/hr) × Dextrose concentration (%) × 10] / [Weight (kg) × 60]. Simplified: GIR = (D × DIR) / 6, where D = dextrose %, DIR = infusion rate in mL/kg/hr
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| infusion_rate | float | Yes | Intravenous infusion rate of dextrose solution in mL/hr(mL/hr) |
| dextrose_concentration | float | Yes | Concentration of dextrose in the IV solution as percentage (e.g., 5% = 5.0, 10% = 10.0, 12.5% = 12.5)(%) |
| weight | float | Yes | Patient weight in kilograms. Essential for calculating per-kilogram dosing in pediatric and neonatal care(kg) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–3.9 | Below Normal Range | Insufficient glucose delivery |
| 4–8 | Normal/Physiologic Range | Appropriate glucose delivery |
| 8.1–12 | Moderate/Therapeutic Range | Enhanced glucose delivery |
| 12.1–18 | High Therapeutic Range | High glucose delivery for nutrition |
| 18.1–50 | Excessive Range | Risk of metabolic complications |
Evidence-Based References (EBM)
- Kalhan SC, Parimi PS. Gluconeogenesis in the fetus and neonate. Semin Perinatol. 2000;24(2):94-106. doi: 10.1053/sp.2000.6360.DOI: 10.1053/sp.2000.6360
- Ditzenberger GR, Collins SD, Binder N. Continuous insulin infusion in the management of hyperglycemia in the pediatric intensive care unit. Pediatr Crit Care Med. 2004;5(1):27-32. doi: 10.1097/01.PCC.0000102223.83245.02.DOI: 10.1097/01.PCC.0000102223.83245.02
- Sinclair JC, Bottino M, Cowett RM. Interventions for prevention of neonatal hyperglycemia in very low birth weight infants. Cochrane Database Syst Rev. 2011;(10):CD007615. doi: 10.1002/14651858.CD007615.pub3.DOI: 10.1002/14651858.CD007615.pub3
- Hay WW Jr, Raju TN, Higgins RD, Kalhan SC, Devaskar SU. Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia: workshop report from Eunice Kennedy Shriver National Institute of Child Health and Human Development. J Pediatr. 2009;155(5):612-617. doi: 10.1016/j.jpeds.2009.06.044.DOI: 10.1016/j.jpeds.2009.06.044